0001209191-22-046598.txt : 20220818 0001209191-22-046598.hdr.sgml : 20220818 20220818160727 ACCESSION NUMBER: 0001209191-22-046598 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220816 FILED AS OF DATE: 20220818 DATE AS OF CHANGE: 20220818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brandt Peter C. CENTRAL INDEX KEY: 0001434099 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39692 FILM NUMBER: 221177569 MAIL ADDRESS: STREET 1: NOVEN PHARMACEUTICALS, INC. STREET 2: 11960 SW 144TH STREET CITY: MIAMI STATE: FL ZIP: 33186 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IN8BIO, INC. CENTRAL INDEX KEY: 0001740279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825462585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 BUSINESS PHONE: (646) 600-6438 MAIL ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 FORMER COMPANY: FORMER CONFORMED NAME: Incysus Therapeutics, Inc. DATE OF NAME CHANGE: 20180510 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-16 0 0001740279 IN8BIO, INC. INAB 0001434099 Brandt Peter C. C/O IN8BIO, INC. 350 5TH AVE. SUITE 5330 NEW YORK NY 10118 1 0 0 0 Common Stock 2022-08-16 4 P 0 105263 1.90 A 182473 D Common Stock 105290 I See footnote Includes 77,210 shares received as an annual annuity payment from the Reporting Person's GRAT. This transfer constitutes a mere change in the form of ownership and is exempt from reporting pursuant to Rule 16a-13. The securities are held by The Peter C. Brandt 2020-4 GRAT (the "GRAT"). The Reporting Person is the trustee of the GRAT and, as such, has voting and investment power over the shares held by the GRAT. /s/ Jason Minio, Attorney-in-Fact 2022-08-18